This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gentry, D. R.
Right arrow Articles by Holmes, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gentry, D. R.
Right arrow Articles by Holmes, D. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2007, p. 2048-2052, Vol. 51, No. 6
0066-4804/07/$08.00+0     doi:10.1128/AAC.01066-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Stepwise Exposure of Staphylococcus aureus to Pleuromutilins Is Associated with Stepwise Acquisition of Mutations in rplC and Minimally Affects Susceptibility to Retapamulin{triangledown}

Daniel R. Gentry,* Stephen F. Rittenhouse, Lynn McCloskey, and David J. Holmes

Department of Microbiology, MMPD-CEDD, GlaxoSmithKline, Collegeville, Pennsylvania 19426

Received 23 August 2006/ Returned for modification 4 October 2006/ Accepted 20 March 2007

To assess their effects on susceptibility to retapamulin in Staphylococcus aureus, first-, second-, and third-step mutants with elevated MICs to tiamulin and other investigational pleuromutilin compounds were isolated and characterized through exposure to high drug concentrations. All first- and second-step mutations were in rplC, encoding ribosomal protein L3. Most third-step mutants acquired a third mutation in rplC. While first- and second-step mutations did cause an elevation in tiamulin and retapamulin MICs, a significant decrease in activity was not seen until a third mutation was acquired. All third-step mutants exhibited severe growth defects, and faster-growing variants arose at a high frequency from most isolates. These faster-growing variants were found to be more susceptible to pleuromutilins. In the case of a mutant with three alterations in rplC, the fast-growing variants acquired an additional mutation in rplC. In the case of fast-growing variants of isolates with two mutations in rplC and at least one mutation at an unmapped locus, one of the two rplC mutations reverted to wild type. These data indicate that mutations in rplC that lead to pleuromutilin resistance have a direct, negative effect on fitness. While reduction in activity of retapamulin against S. aureus can be seen through mutations in rplC, it is likely that target-specific resistance to retapamulin will be slow to emerge due to the need for three mutations for a significant effect on activity and the fitness cost of each mutational step.

* Corresponding author. Mailing address: UP1345, GlaxoSmithKline, 1250 S. Collegeville Road, Collegeville, PA 19426. Phone: (610) 917-7504. Fax: (610) 917-7901. E-mail: dan.r.gentry{at}gsk.com

{triangledown} Published ahead of print on 2 April 2007.

Antimicrobial Agents and Chemotherapy, June 2007, p. 2048-2052, Vol. 51, No. 6
0066-4804/07/$08.00+0     doi:10.1128/AAC.01066-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Kilaru, S., Collins, C. M., Hartley, A. J., Bailey, A. M., Foster, G. D. (2009). Establishing Molecular Tools for Genetic Manipulation of the Pleuromutilin-Producing Fungus Clitopilus passeckerianus. Appl. Environ. Microbiol. 75: 7196-7204 [Abstract] [Full Text]  
  • Traczewski, M. M., Brown, S. D. (2008). Proposed MIC and Disk Diffusion Microbiological Cutoffs and Spectrum of Activity of Retapamulin, a Novel Topical Antimicrobial Agent. Antimicrob. Agents Chemother. 52: 3863-3867 [Abstract] [Full Text]  
  • Woodford, N., Afzal-Shah, M., Warner, M., Livermore, D. M. (2008). In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin. J Antimicrob Chemother 62: 766-768 [Abstract] [Full Text]  
  • Miller, K., Dunsmore, C. J., Fishwick, C. W. G., Chopra, I. (2008). Linezolid and Tiamulin Cross-Resistance in Staphylococcus aureus Mediated by Point Mutations in the Peptidyl Transferase Center. Antimicrob. Agents Chemother. 52: 1737-1742 [Abstract] [Full Text]  
  • Daum, R. S. (2007). Skin and Soft-Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus. NEJM 357: 380-390 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»